- Sep 14th, 2006
New England Journal reports on dendritic treatment for melanoma
- Sep 7th, 2006
Northwest Biotherapeutics Receives FDA Clearance for Lung Cancer Trial
- May 27th, 2006
Vaccines usher in new season of hope. Cancer researchers are on a search-and-destroy mission to fight
- Apr 2nd, 2006
A new “super institute” created by merging two key Victorian medical research
- Aug 2nd , 2005
Northwest Biotherapeutics Announces Appointment of Paul Zeltzer, MD as Medical Director
- May 13th, 2005
A new therapeutic vaccine revolutionizes patients’ fight with the illness
- Apr 17th, 2005
New Frontiers in Oncology, Conference in Cambridge, UK, September
- Jan 31st, 2005
Northwest Biotherapeutics, Inc. to Initiate Phase III Clinical Trial for Prostate Cancer
- Oct 20th, 2004
Introgen’s INGN 225 Therapy Demonstrates Powerful New Combined DC Approach to Cancer
- Sep 30th, 2004
Aastrom Biosciences Awarded NIH Grant for Study to Enhance Dendritic Cell- Based Cancer
- Sep 29th, 2004
A novel gene (designated PHOR-1) that is highly over-expressed in prostate and other cancers
- Aug 29th, 2004
The body’s defence system recognises harmful invaders much quicker than previously
- Jun 23rd, 2004
New Weapon Against Pancreatic Cancer Found
- Jun 18th, 2004
Small interfering RNA can enhance Th1 immune response
- Jun 09th, 2004
Patients’ cells used to attack cancer
- May 26th, 2004
Dendritic cell vaccine quells GI tumors in mice
- May 24th, 2004
New technology blocks gene to increase immune response against deadly brain tumor cells
- Apr 04th, 2004
Duke Scientists Overcome Immune Resistance In Dendritic Cell Vaccines For Cancer
- Mar 17th, 2004
Dendritic cells can be manipulated to induce specific antitumor response
- Jan 18th, 2004
Cancer vaccine helps locals But the treatment is only available in Argentina–
- Jan 16th, 2004
Telomerase pulsed dendritic cells could aid renal cell carcinoma immunotherapy
- Nov 05th, 2003
Melanoma vaccine with GM-CSF elicits strong response in phase II trial
- Sep 10th, 2003
Uric acid is principal mediator of immune response after tissue damage
- Aug 22nd, 2003
New genetic technique can generate hybrid cancer vaccines
- Jun 27th, 2003
Lentiviral vaccine injection transduces DCs, elicits T-cell response in mice
- Jun 02nd, 2003
Cancer vaccine shows promise in phase I human trial
- Mar 25th, 2003
Mature dendritic cells in breast tumors linked to improved survival
- Mar 14th, 2003
Intratumoral dendritic cell vaccination prolongs survival in rat glioma
- Jan 09th, 2003
Success reported in early trial of melanoma gene therapy vaccine
- Dec 12th, 2002
SABCS: Dendritic Vaccine Shows Promise for Metastatic Breast Cancer
- Nov 25th, 2002
Autologous dendritic cell-based immunotherapy tested in childhood cancer
- Oct 02nd, 2002
Dendritic cell therapy after low-dose chemotherapy induces potent tumor-specific immunity
- Mar 27th, 2002
Idiotype-pulsed dendritic cell vaccination can induce regression of B-cell NHL
- Mar 26th, 2002
In vivo manipulation of dendritic cells induces immunity in mice
- Mar 12th, 2002
Dendritic cells engraftment rapidly follows hematopoietic cell transplantation
- Feb 06th, 2002
Prolonging antigen presentation on dendritic cells enhances antitumor immunity
- Dec 24th, 2001
In situ dendritic-cell tumor vaccine uses subcutaneous chemotactic implant
- Oct 2001
Dendritic Cells Proving Key to Prostate Cancer Immunotherapy
- Aug 20th, 2001
HER2-transduced dendritic cells generate T killer and Th cell clones
- May 27th, 2001
Dendritic Cell Vaccine Helps Fight Children’s Cancer
- May 17th, 2001
Tumor cell vaccine safe for patients with non-small-cell lung cancer
- May 15th, 2001
Cancer vaccine shows promise against colorectal cancer
- Feb 23rd, 2001
Dendritic cell vaccines may improve cancer immunotherapy
- Jan 31st, 2001
New dendritic cell vaccine elicits beneficial immune response in glioma patients
- Sep 04th, 2000
Fused ovarian cancer and dendritic cells stimulate T-cell response against tumor
- Sep 01st, 2000
Dendritic cells pulsed with ovarian cancer peptides stimulate specific CTL response
- Aug 07th, 2000
Cancer – Engineered Dendritic Cells Enhance T-Cell Responses
- Jul 21st, 2000
Vaccine based on dendritic cells appears safe in early trials of multiple myeloma
- Jun 30th, 2000
CD40L-expressing dendritic cells promote tumor regression in mice
- Jun 15th, 2000
Unpulsed dendritic cells can elicit antitumor effect
- Jun 05th, 2000
Immunotherapy is feasible therapeutic approach to multiple myeloma
- Feb 03rd, 2000
Dendritic cell vaccines being tested on astrocytomas
- Apr 5th, 2000
UCLA Johnsson Cancer Center Discovery Method to Boost Immune System
Like this:
Like Loading...